Healio
Noninvasive diagnostic retinal testing could possibly hold the answer to early Alzheimer’s disease detection and treatment. The PRIMARY CARE OPTOMETRY NEWS August cover story details how retinal testing may detect amyloid beta protein deposits, the biomarker of Alzheimer’s disease.
Keep up with our latest articles, news and events. Plus, get special offers and more delivered to your inbox.
OptometryWeb wants to hear from you. Submit your case studies, clinical pearls, practice management tips, editorial, or other manuscripts.
Learn more about writing for us